Clarity Pharmaceuticals Ltd.ASX: CU6

COMBAT theranostic prostate cancer trial commences in the US

Jun 20, 2023 at 3:36 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment